AAO: Intravitreal Shots Carry Risk Of Persistent Glaucoma

Tuesday, October 27, 2009

Comments

medpageToday

SAN FRANCISCO -- Intravitreal injections of vascular endothelial growth factor (VEGF) inhibitors can cause persistent hypertension in the eye after only one treatment, researchers found.

Full Story

The patient depicted in the photo was scheduled for a surgical procedure which was aborted at the beginning of the case. The photo was taken 2 weeks after the scheduled surgery. What was the most likely intraoperative event?
1. post injection retrobulbar hematoma
2. infection from nonsterile instruments
3. cautery fire
4. allergic reaction to surgical drapes
Check The Answer

CareCloud Central
CareCloud Central is a medical practice ... view product
SPECTRALIS Diagnostic Imaging Platform
A modular and upgradeable ophthalmic ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us

AdGlare Leaderboard

AAO: Intravitreal Shots Carry Risk Of Persistent Glaucoma

Comments

Related Categories

Refractive Products and Equipment »

Glaucoma Testing Equipment / Glaucoma Products »

Quick Quiz

The patient depicted in the photo was scheduled for a surgical procedure which was aborted at the beginning of the case. The photo was taken 2 weeks after the scheduled surgery. What was the most likely intraoperative event?

AdGlare RMR Ad

Featured Products

CareCloud Central

SPECTRALIS Diagnostic Imaging Platform

Follow OphthalmologyWeb

AdGlare RMR2

Write for Us